EYPT Jun 2024 20.000 call
| Previous Close | 0.0600 |
| Open | 3.0000 |
| Bid | 0.0000 |
| Ask | 0.1500 |
| Strike | 20.00 |
| Expire Date | 2024-06-21 |
| Day's Range | 0.0600 - 3.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 5 |
Simply Wall St.Investing in EyePoint Pharmaceuticals (NASDAQ:EYPT) a year ago would have delivered you a 91% gain
The last three months have been tough on EyePoint Pharmaceuticals, Inc. ( NASDAQ:EYPT ) shareholders, who have seen the...
GuruFocus.comInsider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
On May 14, 2024, David Guyer, Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a sale of 11,625 shares of the company.
GlobeNewswireEyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an a
